| Dr Michael Alan Dehuff, MD | |
|
1 S Bryant Ave, Edmond, OK 73034-6309 | |
| (918) 664-9892 | |
| (918) 392-2945 |
| Full Name | Dr Michael Alan Dehuff |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 1 S Bryant Ave, Edmond, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396726527 | NPI | - | NPPES |
| 100022820B | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 17040 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Alan Dehuff, MD 4500 S Garnett Rd, Suite 300, Tulsa, OK 74146-5229 Ph: (918) 664-9892 | Dr Michael Alan Dehuff, MD 1 S Bryant Ave, Edmond, OK 73034-6309 Ph: (918) 664-9892 |
News Archive
Enanta Pharmaceuticals, Inc., a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, announced today that new Phase 2b data related to ABT-450, Enanta's lead HCV protease inhibitor identified in its ongoing collaboration with AbbVie, as well as new preclinical data on Enanta's proprietary cyclophilin inhibitor, EDP-546, will be presented at the International Liver Congress, which is the 48th Annual Meeting of the European Association for the Study of the Liver taking place in Amsterdam April 24-28, 2013.
Biostar Pharmaceuticals, Inc., a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today announced it has signed a letter of intent ("LOI') with a Xi'an-based medical equipment and nutrients manufacturer ("Acquiree") to acquire 100% of the Acquiree for $1.1 million in cash.
Results from a Mayo Clinic laboratory study in animals suggest that using distraction osteogenesis, a procedure that uses the mechanical force of an appliance to lengthen soft tissue and bone, may be a feasible and effective method to repair cleft palate in the future.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Novartis' breast cancer treatment Femara® (letrozole) Tablets, 2.5 mg. Final approval of Teva's Letrozole Tablets is expected upon expiry of patent protection for the brand product in June 2011.
How women think their friends feel about their bodies influences their own body concerns, according to a new study by Dr. Louise Wasylkiw and Molly Williamson from Mount Alison University in Canada. Their work, which examines the role of friends in young women's body concerns, is published online in Springer's journal Sex Roles.
› Verified 8 days ago
Dr. Dipakkumar Shantilal Patel, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 11312 Old River Trl, Edmond, OK 73013 Phone: 405-796-7234 | |
Dr. Lloyd Robert Chance, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1800 Renaissance Blvd, Edmond, OK 73013 Phone: 405-359-2400 | |
Jeffrey Newton Pearce, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 110 N Midwest Blvd, Edmond, OK 73034 Phone: 405-209-8293 | |
Dr. Charles C Weddle Jr., M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1800 Renaissance Blvd, Edmond, OK 73013 Phone: 405-359-2400 | |
Eric J Neller, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1800 Renaissance Blvd, Edmond, OK 73013 Phone: 405-359-2400 | |
Dr. Thomas Covington Pratt, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 S Bryant Ave, Edmond, OK 73034 Phone: 918-664-9892 Fax: 918-664-2521 |